Tag: Health Care

Displaying 101 - 120 of 802 results.

An administrator working for the Federal Trade Commission is mailing 2,546 checks averaging $71.71 each to consumers who bought Accelis, nanoSLIM, and any Cold MD, Germ MD, or Allergy MD dietary supplements between January 2006 and July 2010. The FTC charged Iovate Health Sciences U.S.A. and two...
The Federal Trade Commission filed a complaint against medical testing laboratory LabMD, Inc. alleging that the company failed to reasonably protect the security of consumers’ personal data, including medical information.  The complaint alleges that in two separate incidents, LabMD collectively...
The Federal Trade Commission today announced the following actions. The FTC staff contact, unless otherwise noted, is Dan Ducore, 202-326-2526. Applications for prior approval of transactions:The FTC has received applications for prior approval of divestitures from the following. The applications...
The largest U.S. supplier of diagnostic testing products used by small animal veterinarians, IDEXX Laboratories, Inc., agreed to drop its exclusive-dealing arrangements with a top distributor, resolving FTC charges that it was using the exclusive arrangements to stifle competition....
The Federal Trade Commission, the nation’s consumer protection agency, will host a roundtable in Washington, D.C., on September 19, 2013, to discuss how to empower and protect consumers from scammers with the advent of healthcare marketplaces opening this fall under the Affordable Care Act (ACA).
The Hospital Authority of Albany-Dougherty County andPhoebe Putney Health System, Inc. have agreed to settle Federal Trade Commission charges that the acquisition ofPalmyra Park Hospital harmed hospital competition in six Georgia counties.  The proposed consent includes provisions to aid...
Two marketers of unproven cedar oil-based remedies for bed bugs and head lice have agreed to enter into settlements with the Federal Trade Commission that prohibit the allegedly deceptive claims, and require pre-approval from the Food and Drug Administration for any future treatment claims about...
The Federal Trade Commission told a Senate Judiciary subcommittee today that it will continue to challenge anticompetitive pay-for-delay court settlements in the pharmaceutical industry, and that the recent U.S. Supreme Court decision in FTC v. Actavis “is an important victory for consumers and a...
The Federal Trade Commission has mailed 10,144 checks to consumers who bought Disney- or Marvel Hero-themed vitamins for their kids that featured characters such as the Disney Princesses, Winnie the Pooh, Finding Nemo, and Spider-Man.
A physician group in the Dallas/Fort Worth, Texas area settled charges that it collectively bargained on behalf of its members to negotiate fee schedules with third party payers and other health insurance companies. According to the complaint, issued with the consent order, these...
The consent order protects competition in three medical device product markets affected by Johnson & Johnson’s proposed $25.4 billion acquisition of Guidant Corporation.
The consent order allowed Teva to acquire IVAX Corporation, provided the companies sell the rights and assets needed to manufacture and market 15 generic pharmaceutical products. Among the drugs sold were several forms of generic amoxicillin and amoxicillin clavulanate potassium that...
The consent order requires that Allergan and Inamed divest the rights to develop and distribute Reloxin, a potential Botox rival, to settle charges that Allergan’s $3.2 billion purchase of Inamed would reduce competition and force consumers to pay higher prices for botulinum toxin...
Fresenius AG settled charges that its purchase of rival dialysis provider Renal Care Group, Inc. would likely have resulted in higher prices for dialysis services. The consent order requires that Fresenius AG will sell 91 outpatient kidney dialysis clinics and financial interests in...
The Commission charged that Schering-Plough’s proposed $14.4 billion acquisition of Organon Biosciences N.V. threatened to substantially reduce competition in the U.S. market for three popular vaccines used to treat poultry, a staple in American food markets. The November 2007 order...
The Commission charged that Schering-Plough’s proposed $14.4 billion acquisition of Organon Biosciences N.V. threatened to substantially reduce competition in the U.S. market for three popular vaccines used to treat poultry, a staple in American food markets. The November 2007 order...
The Commission authorized both an administrative complaint and a motion for a preliminary injunction to challenge the proposed merger of Inova Health System Foundation’s and Prince William Health System (PWHS), alleging that the acquisition would violate federal antitrust laws by...
The Commission charged that Sun Pharmaceutical Industries Ltd’s proposed acquisition of Taro Pharmaceuticals Industries, Ltd would substantially reduce competition, likely resulting in higher prices for three distinct generic formulations of the anticonvulsant drug carbamazepine,...
The Commission settled charges that the executive director of a Colorado physicians’ association actively tried to evade the terms of a 2008 FTC order by telling insurers that because she was not named individually in the order, she could simply negotiate on behalf of competing...
To settle FTC charges that its proposed acquisition of Alcon, Inc., would be anticompetitive, Novartis AG agreed to sell an injectable eye care drug used in cataract surgery. Novartis and Alcon are the only two U.S. providers of the class of drugs known as injectable miotics, and the...

Pages